Get access

Reopening the case for anti–basal ganglia antibodies (ABGAs): Identification of dopamine-2 receptor antibodies associated with movement disorders

Authors


  • Financial Disclosures: Bettina Balint has nothing to disclose. Kailash Bhatia: advisor/honoraria/financial support to speak/attend meetings from GSK, Boehringer-Ingelheim, Ipsen, Merz, and Orion pharma companies. Grants by the Dystonia Society UK and the Halley Stewart Trust.

No abstract is available for this article.

Ancillary